查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2105678

2026-2034年生物材料傷口敷料全球市場規模、佔有率、趨勢和成長分析報告

Global Biomaterial Wound Dressing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球生物材料傷口敷料市場預計將從2025年的71.4億美元成長至2034年的126.7億美元，2026年至2034年的複合年成長率（CAGR）為6.58%。隨著醫療專業人員擴大使用先進的生物材料來加速創傷治療和降低感染風險，該市場正經歷強勁成長。生物材料傷口敷料旨在促進組織再生、維持最佳濕度水平並加速慢性傷口、燒燙傷和手術損傷的恢復。糖尿病盛行率的上升、人口老化以及人們對先進創傷護理解決方案的日益關注，正在推動醫院和居家醫療機構對生物材料傷口敷料的廣泛應用。

製造商正投資研發創新生物材料、生物活性化合物和抗菌技術，以改善傷口癒合和提升患者舒適度。組織工程、再生醫學和可生物分解材料的進步，推動了高效創傷護理產品的開發。醫療成本的不斷上漲以及對縮短住院時間的日益重視，創造了有利的市場機會。專業創傷護理中心的擴張也為該行業的持續成長提供了支持。

隨著再生醫學和個人化醫療的不斷發展，前景依然十分光明。整合感測器和遠端監測技術的智慧傷口敷料將提高治療效果和患者管理水平。增加對生技研發和醫療基礎設施的投資將進一步加速產品創新。新一代生物材料的持續研發將鞏固市場，並改善全球患者的長期治療效果。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球生物材料傷口敷料市場：依材料類型分類

  • 市場分析、洞察與預測
  • 天然成分（藻酸鹽、膠原蛋白蛋白、幾丁聚醣、羧甲基纖維素（CMC）及其他天然成分）
  • 合成材料（聚氨酯、矽酮、聚乙烯醇和其他合成材料）

第5章 全球生物材料傷口敷料市場：依應用領域分類

  • 市場分析、洞察與預測
  • 慢性傷口（壓瘡、糖尿病足潰瘍、靜脈性下肢潰瘍及其他慢性傷口）
  • 急性傷口（外科性創傷、外傷、燒傷）

第6章 全球生物材料傷口敷料市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 居家醫療
  • 其他最終用戶

第7章 全球生物材料傷口敷料市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • 3M Company
    • B. Braun Melsungen
    • ConvaTec
    • DermaRite Industries
    • Hollister Incorporated
    • Integra LifeSciences
    • Johnson & Johnson
    • Medtronic
    • Molnlycke Health Care
    • Smith & Nephew
    • Coloplast A/S
    • Cardinal Health
    • Advanced Medical Solutions
    • PAUL HARTMANN AG
    • Lohmann & Rauscher
    • Organogenesis Holdings
    • Essity AB（BSN Medical）
簡介目錄
Product Code: VMR112119288

The global biomaterial wound dressing market size is expected to reach USD 12.67 Billion in 2034 from USD 7.14 Billion in 2025, growing at a CAGR of 6.58 during 2026-2034.This market is experiencing strong growth as healthcare providers increasingly utilize advanced biomaterials to improve wound healing and reduce infection risks. Biomaterial wound dressings are designed to support tissue regeneration, maintain optimal moisture levels, and accelerate recovery for chronic wounds, burns, and surgical injuries. Rising incidence of diabetes, expanding elderly populations, and increasing awareness of advanced wound care solutions are driving greater adoption across hospitals and home healthcare settings.

Manufacturers are investing in innovative biomaterials, bioactive compounds, and antimicrobial technologies that improve healing outcomes and patient comfort. Advances in tissue engineering, regenerative medicine, and biodegradable materials are enabling the development of highly effective wound care products. Increasing healthcare expenditure and stronger emphasis on reducing hospitalization periods are creating favorable market opportunities. Expansion of specialized wound care centers is also supporting sustained industry growth.

The future outlook remains highly positive as regenerative medicine and personalized healthcare continue advancing. Smart wound dressings incorporating sensors and remote monitoring technologies will improve treatment effectiveness and patient management. Growing investments in biotechnology research and healthcare infrastructure will further accelerate product innovation. Continuous development of next-generation biomaterials will strengthen the market and improve long-term patient outcomes worldwide.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Material Type

  • Natural (Alginate, Collagen, Chitosan, Carboxymethyl Cellulose (CMC), Other Natural Materials)
  • Synthetic (Polyurethane, Silicone, Polyvinyl Alcohol, Other Synthetic Materials)

By Application

  • Chronic Wounds (Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Other Chronic Wounds)
  • Acute Wounds (Surgical & Traumatic Wounds, Burns)

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Other End Users

COMPANIES PROFILED

  • 3M Company, B. Braun Melsungen, ConvaTec, DermaRite Industries, Hollister Incorporated, Integra LifeSciences, Johnson & Johnson, Medtronic, Molnlycke Health Care, Smith & Nephew, Coloplast A/S, Cardinal Health, Advanced Medical Solutions, PAUL HARTMANN AG, Lohmann & Rauscher, Organogenesis Holdings, Essity AB (BSN Medical)

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOMATERIAL WOUND DRESSING MARKET: BY MATERIAL TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Material Type
  • 4.2. Natural (Alginate, Collagen, Chitosan, Carboxymethyl Cellulose (CMC), Other Natural Materials) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Synthetic (Polyurethane, Silicone, Polyvinyl Alcohol, Other Synthetic Materials) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOMATERIAL WOUND DRESSING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Chronic Wounds (Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Other Chronic Wounds) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Acute Wounds (Surgical & Traumatic Wounds, Burns) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOMATERIAL WOUND DRESSING MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOMATERIAL WOUND DRESSING MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Material Type
    • 7.2.2 By Application
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Material Type
    • 7.3.2 By Application
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Material Type
    • 7.4.2 By Application
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Material Type
    • 7.5.2 By Application
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Material Type
    • 7.6.2 By Application
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOMATERIAL WOUND DRESSING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 3M Company
    • 9.2.2 B. Braun Melsungen
    • 9.2.3 ConvaTec
    • 9.2.4 DermaRite Industries
    • 9.2.5 Hollister Incorporated
    • 9.2.6 Integra LifeSciences
    • 9.2.7 Johnson & Johnson
    • 9.2.8 Medtronic
    • 9.2.9 Molnlycke Health Care
    • 9.2.10 Smith & Nephew
    • 9.2.11 Coloplast A/S
    • 9.2.12 Cardinal Health
    • 9.2.13 Advanced Medical Solutions
    • 9.2.14 PAUL HARTMANN AG
    • 9.2.15 Lohmann & Rauscher
    • 9.2.16 Organogenesis Holdings
    • 9.2.17 Essity AB (BSN Medical)